Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $392.6 million.

  • Marimed's Shares Outstanding (Weighted Average) rose 315.66% to $392.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $392.6 million, marking a year-over-year increase of 315.66%. This contributed to the annual value of $379.2 million for FY2024, which is 433.4% up from last year.
  • As of Q3 2025, Marimed's Shares Outstanding (Weighted Average) stood at $392.6 million, which was up 315.66% from $389.9 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Shares Outstanding (Weighted Average) ranged from a high of $392.6 million in Q3 2025 and a low of $305.2 million during Q1 2021
  • For the 5-year period, Marimed's Shares Outstanding (Weighted Average) averaged around $355.5 million, with its median value being $361.3 million (2023).
  • Per our database at Business Quant, Marimed's Shares Outstanding (Weighted Average) surged by 3222.42% in 2021 and then surged by 195.78% in 2025.
  • Marimed's Shares Outstanding (Weighted Average) (Quarter) stood at $326.5 million in 2021, then rose by 3.44% to $337.7 million in 2022, then rose by 7.61% to $363.4 million in 2023, then rose by 4.33% to $379.2 million in 2024, then rose by 3.55% to $392.6 million in 2025.
  • Its last three reported values are $392.6 million in Q3 2025, $389.9 million for Q2 2025, and $382.6 million during Q1 2025.